Whan In Pharm Co.,Ltd. (KRX:016580)

South Korea · Delayed Price · Currency is KRW

9,600.00

-50.00 (-0.52%)

Jun 24, 2026, 3:30 PM KST

-19.26% (1Y)

Market Cap	178.37B +3.7%
Revenue (ttm)	266.19B +3.1%
Net Income	15.94B -18.0%
EPS	956.82 -24.8%
Shares Out	18.48M
PE Ratio	10.09
Forward PE	8.41
Dividend	300.00 (3.06%)
Ex-Dividend Date	Dec 29, 2025

Volume	45,750
Open	9,650.00
Previous Close	9,650.00
Day's Range	9,460.00 - 9,730.00
52-Week Range	9,460.00 - 13,210.00
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 27, 2026

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products, such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitami... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1978

Employees 634

Stock Exchange Korea Stock Exchange

Ticker Symbol 016580

Full Company Profile

Financial Performance

In 2025, Whan In Pharm's revenue was 255.21 billion, a decrease of -1.69% compared to the previous year's 259.60 billion. Earnings were 13.60 billion, a decrease of -41.85%.

Financial Statements